Search

everythinglearnresearchcommunity

for

Search:↓

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A man in Japan got better from a scalp fungal infection using terbinafine.

DPCP is more effective than tretinoin gel for treating severe alopecia.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Bandotan leaf extract effectively promotes hair growth.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Thyroid hormone receptor β1 is found in human hair follicles and helps them survive.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Tadalafil and Finasteride may help treat aggressive melanoma.

TSG from Polygonum multiflorum may help with anti-aging by protecting the brain, heart, bones, and hair.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

The drug combination significantly reduced epileptic drop attacks in patients.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.